MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F1992 to DMS Pharmaceutical Group Inc under the overarching delivery order SPE2DX15D9383. The primary objective of this award was the procurement of Meloxicam Tablets, identified by NSN 6505015413243. The broader delivery order SPE2DX-15-D-9383 is established as a contract for commercial items with a total award value of 4,999,999.00 dollars. Despite the initial award, modification P00001 was issued on August 25, 2026, resulting in the total cancellation of CLIN 0001. This action was taken for the governments convenience under FAR 52.249-1 to address aged and undelivered orders. Consequently, the specific order amount for this line item was decreased by 3.01 dollars, bringing the total value of this specific award notice to 0.00 dollars with no cost or liability incurred.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
